Korea Q2 Roundup: In-House Drugs, Exports Help Hanmi, Daewoong, Boryung

 
• By Jung Won Shin

Among the strong performers, Hanmi benefitted from growth for in-house-developed metabolic disease drugs and China cold syrup sales and Daewoong was boosted by exports of botulinum toxin, while Boryung reported record quarterly sales helped by its flagship antihypertensive.

earnings
Boryung, Daewoong Report Record Quarterly Earnings On Flagship Cash Cows • Source: Shutterstock

More from South Korea

More from Focus On Asia